Physician profile
Julia Beth Becker
NPI 1902969546
$337.14
in general payments reported to CMS, 2019-2025
11 companies · $21.72 in 2025
The $21.72 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.52 · 2021: $55.45 · 2022: $92.75 · 2023: $38.98 · 2024: $92.72 · 2025: $21.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $70.23 | 2022-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $63.29 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.62 | 2021 | |
| Csl Behring | $19.24 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.58 | 2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.38 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.27 | 2022 | |
| Inari Medical, INC. | $17.94 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medical Graphics Corporation | $16.28 | 2020 | |
| Amgen INC. | $15.83 | 2024 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.